NEUROCRINE BIOSCIENCES INC Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neurocrine Biosciences Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Neurocrine Biosciences Inc Return On Equity for the quarter ending June 30, 2024 was 14.9 %, a 43% increase year-over-year.
  • Neurocrine Biosciences Inc annual Return On Equity for 2023 was 12.9 %, a 26.2% increase from 2022.
  • Neurocrine Biosciences Inc annual Return On Equity for 2022 was 10.2 %, a 47.9% increase from 2021.
  • Neurocrine Biosciences Inc annual Return On Equity for 2021 was 6.89 %, a 85.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 14.9 +4.47 +43% Apr 1, 2024 Jun 30, 2024
Q1 2024 17.5 +13.4 +334% Jan 1, 2024 Mar 31, 2024
Q4 2023 12.9 +2.67 +26.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 10.5 +6.48 +160% Jul 1, 2023 Sep 30, 2023
Q2 2023 10.4 +9.51 +1079% Apr 1, 2023 Jun 30, 2023
Q1 2023 4.02 -1.27 -24% Jan 1, 2023 Mar 31, 2023
Q4 2022 10.2 +3.3 +47.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 4.06 -31.8 -88.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 0.88 -32.2 -97.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 5.3 -35.2 -86.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 6.89 -40.2 -85.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 35.9 +23.3 +186% Jul 1, 2021 Sep 30, 2021
Q2 2021 33 +3.17 +10.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 40.5 +11.1 +37.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 47.1 +40 +569% Oct 1, 2020 Dec 31, 2020
Q3 2020 12.6 +8.24 +190% Jul 1, 2020 Sep 30, 2020
Q2 2020 29.9 +25.9 +654% Apr 1, 2020 Jun 30, 2020
Q1 2020 29.5 +38.6 Jan 1, 2020 Mar 31, 2020
Q4 2019 7.03 +1.98 +39.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 4.33 +1.78 +70% Jul 1, 2019 Sep 30, 2019
Q2 2019 3.96 +18.2 Apr 1, 2019 Jun 30, 2019
Q1 2019 -9.14 +20.5 +69.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 5.06 +48.5 Oct 1, 2018 Dec 31, 2018
Q3 2018 2.54 +64.4 Jul 1, 2018 Sep 30, 2018
Q2 2018 -14.2 +55.6 +79.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -29.7 +32.2 +52% Jan 1, 2018 Mar 31, 2018
Q4 2017 -43.5 -4.81 -12.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -61.9 -29.8 -93.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -69.9 -40.2 -136% Apr 1, 2017 Jun 30, 2017
Q1 2017 -61.8 -37.4 -153% Jan 1, 2017 Mar 31, 2017
Q4 2016 -38.6 -19.1 -98% Oct 1, 2016 Dec 31, 2016
Q3 2016 -32 -12.4 -62.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -29.6 -12.1 -69.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -24.4 -7.15 -41.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -19.5 +6.91 +26.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -19.7 +5.31 +21.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -17.5 +8.14 +31.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -17.3 +11.7 +40.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -26.4 +8.32 +23.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -25 -6.6 -35.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -25.6 -13.3 -107% Apr 1, 2014 Jun 30, 2014
Q1 2014 -29 -24.8 -591% Jan 1, 2014 Mar 31, 2014
Q4 2013 -34.7 -38.2 -1113% Oct 1, 2013 Dec 31, 2013
Q3 2013 -18.4 -15.8 -622% Jul 1, 2013 Sep 30, 2013
Q2 2013 -12.4 -43.2 -140% Apr 1, 2013 Jun 30, 2013
Q1 2013 -4.2 -51.3 -109% Jan 1, 2013 Mar 31, 2013
Q4 2012 3.43 Oct 1, 2012 Dec 31, 2012
Q3 2012 -2.55 Jul 1, 2012 Sep 30, 2012
Q2 2012 30.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 47.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.